FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085460858> ?p ?o ?g. }

• W2085460858 endingPage "492" @default.
• W2085460858 startingPage "483" @default.
• W2085460858 abstract "The in vivo and in vitro effects of human alpha-interferon (IFN) on blood natural killer (NK) cell activity were studied in patients with malignant melanoma. The initial response to an i.m. injection of IFN was a depression of blood NK cell activity, being detectable at 4 h and reaching a nadir at 12 h. Blood NK cell activity returned to or exceeded pretreatment levels within 24 h. The frequency of large granular lymphocytes among peripheral blood lymphocytes (PBL), however, remained unchanged during the first 24 h of IFN treatment. In a single cell cytotoxicity assay in agarose the number of lymphocytes forming conjugates with K562 target cells was not affected at 12-h points of IFN treatment, while the frequency of lytic conjugates with dead target cells was decreased by 12 h. Thus, the number of active NK cells was reduced by IFN administration. While in vitro exposure to IFN resulted in an augmentation of NK cell activity of PBL from untreated patients, IFN failed to enhance the activity of PBL obtained 12 h post IFN injection. When PBL obtained 12 h after IFN injection were cultured overnight, they recovered their responsiveness to NK-boosting effects of IFN. Blood monocytes obtained at 12-h points from IFN-treated patients suppressed IFN-induced enhancement of NK cell activity, although these monocytes did not inhibit the base line level of NK cell activity. In contrast, the streptococcal preparation OK432 was able to augment NK cell activity of PBL obtained 12 h post IFN administration and of control PBL even in the presence of suppressor monocytes. PBL obtained 24 h post IFN injection expressing enhanced NK cell activity were also unresponsive to IFN in vitro. However, monocytes obtained 24 h after IFN injection were no longer able to inhibit IFN-induced augmentation of NK cell activity. These results indicate that in vivo administration of IFN-alpha to cancer patients results in rapid and transient generation of suppressor monocytes capable of inhibiting IFN-dependent development of functional NK cell activity, which could be responsible for the initial and transient decline in blood NK cell activity." @default.
• W2085460858 created "2016-06-24" @default.
• W2085460858 creator A5014575756 @default.
• W2085460858 creator A5035532329 @default.
• W2085460858 creator A5060152257 @default.
• W2085460858 creator A5075118384 @default.
• W2085460858 creator A5083340734 @default.
• W2085460858 date "1984-10-01" @default.
• W2085460858 modified "2023-10-09" @default.
• W2085460858 title "In vitro modulation of human natural killer cell activity by interferon: Generation of adherent suppressor cells" @default.
• W2085460858 cites W130020229 @default.
• W2085460858 cites W1592678890 @default.
• W2085460858 cites W1899980932 @default.
• W2085460858 cites W1981818387 @default.
• W2085460858 cites W1992821447 @default.
• W2085460858 cites W1993319836 @default.
• W2085460858 cites W2003464992 @default.
• W2085460858 cites W2015498548 @default.
• W2085460858 cites W2022285897 @default.
• W2085460858 cites W2045299745 @default.
• W2085460858 cites W2056102936 @default.
• W2085460858 cites W2066177337 @default.
• W2085460858 cites W2074933874 @default.
• W2085460858 cites W2078572186 @default.
• W2085460858 cites W2083338379 @default.
• W2085460858 cites W2143143209 @default.
• W2085460858 cites W2144360148 @default.
• W2085460858 cites W2161082695 @default.
• W2085460858 cites W2162284427 @default.
• W2085460858 cites W2221260322 @default.
• W2085460858 cites W2254359459 @default.
• W2085460858 cites W2271754669 @default.
• W2085460858 cites W2288522020 @default.
• W2085460858 cites W2318152670 @default.
• W2085460858 cites W2414796475 @default.
• W2085460858 doi "https://doi.org/10.1038/bjc.1984.205" @default.
• W2085460858 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1976901" @default.
• W2085460858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6237664" @default.
• W2085460858 hasPublicationYear "1984" @default.
• W2085460858 type Work @default.
• W2085460858 sameAs 2085460858 @default.
• W2085460858 citedByCount "10" @default.
• W2085460858 crossrefType "journal-article" @default.
• W2085460858 hasAuthorship W2085460858A5014575756 @default.
• W2085460858 hasAuthorship W2085460858A5035532329 @default.
• W2085460858 hasAuthorship W2085460858A5060152257 @default.
• W2085460858 hasAuthorship W2085460858A5075118384 @default.
• W2085460858 hasAuthorship W2085460858A5083340734 @default.
• W2085460858 hasBestOaLocation W20854608582 @default.
• W2085460858 hasConcept C109316439 @default.
• W2085460858 hasConcept C129374314 @default.
• W2085460858 hasConcept C1491633281 @default.
• W2085460858 hasConcept C150903083 @default.
• W2085460858 hasConcept C153911025 @default.
• W2085460858 hasConcept C202751555 @default.
• W2085460858 hasConcept C203014093 @default.
• W2085460858 hasConcept C207001950 @default.
• W2085460858 hasConcept C2776090121 @default.
• W2085460858 hasConcept C2776178377 @default.
• W2085460858 hasConcept C2777761686 @default.
• W2085460858 hasConcept C2778102761 @default.
• W2085460858 hasConcept C28651165 @default.
• W2085460858 hasConcept C54355233 @default.
• W2085460858 hasConcept C55493867 @default.
• W2085460858 hasConcept C81885089 @default.
• W2085460858 hasConcept C86803240 @default.
• W2085460858 hasConcept C8891405 @default.
• W2085460858 hasConceptScore W2085460858C109316439 @default.
• W2085460858 hasConceptScore W2085460858C129374314 @default.
• W2085460858 hasConceptScore W2085460858C1491633281 @default.
• W2085460858 hasConceptScore W2085460858C150903083 @default.
• W2085460858 hasConceptScore W2085460858C153911025 @default.
• W2085460858 hasConceptScore W2085460858C202751555 @default.
• W2085460858 hasConceptScore W2085460858C203014093 @default.
• W2085460858 hasConceptScore W2085460858C207001950 @default.
• W2085460858 hasConceptScore W2085460858C2776090121 @default.
• W2085460858 hasConceptScore W2085460858C2776178377 @default.
• W2085460858 hasConceptScore W2085460858C2777761686 @default.
• W2085460858 hasConceptScore W2085460858C2778102761 @default.
• W2085460858 hasConceptScore W2085460858C28651165 @default.
• W2085460858 hasConceptScore W2085460858C54355233 @default.
• W2085460858 hasConceptScore W2085460858C55493867 @default.
• W2085460858 hasConceptScore W2085460858C81885089 @default.
• W2085460858 hasConceptScore W2085460858C86803240 @default.
• W2085460858 hasConceptScore W2085460858C8891405 @default.
• W2085460858 hasIssue "4" @default.
• W2085460858 hasLocation W20854608581 @default.
• W2085460858 hasLocation W20854608582 @default.
• W2085460858 hasLocation W20854608583 @default.
• W2085460858 hasLocation W20854608584 @default.
• W2085460858 hasOpenAccess W2085460858 @default.
• W2085460858 hasPrimaryLocation W20854608581 @default.
• W2085460858 hasRelatedWork W1582412922 @default.
• W2085460858 hasRelatedWork W1939478204 @default.
• W2085460858 hasRelatedWork W1983764257 @default.
• W2085460858 hasRelatedWork W1988929106 @default.
• W2085460858 hasRelatedWork W2020437411 @default.
• W2085460858 hasRelatedWork W2084122311 @default.

• next